Pharmacy NNN Properties in 2026: What Investors Need to Know About CVS, Walgreens, and the Evolving Drug Store Landscape

For decades, pharmacy and drug store chains represented some of the most sought-after assets in the net lease investment universe — long lease terms, investment-grade tenants, and essential-use locations made them a cornerstone of many NNN portfolios. In 2026, however, the sector is undergoing a meaningful reset. Shifting corporate strategies, credit downgrades, and evolving consumer behavior have introduced new layers of complexity that demand careful underwriting and a sharper eye for tenant-level risk.

Cap Rates on the Rise: A Buyer’s Market Emerging

One of the most significant developments entering 2026 is the sustained upward movement in cap rates across pharmacy NNN assets — particularly for Walgreens properties. After years of pricing that reflected the premium status of drug store tenants, cap rates on Walgreens-occupied buildings crossed the 7.8% threshold by the close of 2025 and have continued to reflect investor caution in early 2026. This marks a meaningful departure from the sub-6% environment that characterized peak pharmacy NNN pricing just a few years ago.

For yield-focused buyers, this repricing represents a genuine opportunity — provided the underlying credit, location, and lease structure support the investment thesis. The compression era for pharmacy NNN is behind us, at least for now, and disciplined investors are using that reality to their advantage.

Walgreens: Navigating Structural Headwinds

Walgreens has been the most closely watched name in the pharmacy NNN space over the past 12 to 18 months. The company has faced a combination of operational pressures, including declining front-end retail performance, reimbursement compression on prescription drugs, and an ongoing store rationalization program that has resulted in hundreds of planned closures nationwide. Credit rating agencies have reflected these challenges in their assessments, and NNN investors have responded accordingly by demanding higher yields to compensate for elevated risk.

When underwriting a Walgreens NNN property in 2026, investors should pay close attention to remaining lease term, the presence of renewal options, and — critically — whether the specific location falls within the chain’s identified closure footprint. Properties in dense, high-traffic trade areas with strong underlying real estate fundamentals offer considerably more insulation than those in secondary or tertiary markets with limited alternative tenant demand.

CVS: Relative Stability, but Not Without Challenges

CVS has maintained a comparatively stronger credit profile and more stable operational performance than its primary competitor, which has translated into tighter cap rates and more consistent investor demand for CVS-occupied NNN assets. The company’s diversified business model — spanning pharmacy benefits management, health clinic operations, and insurance through its Aetna subsidiary — provides meaningful revenue diversification that pure-play drug store operators cannot match.

That said, CVS has not been immune to the broader pressures reshaping the pharmacy sector. Reimbursement headwinds and a shifting healthcare delivery landscape have prompted the company to undertake its own strategic realignment. Investors should continue to evaluate individual CVS assets on their merits rather than assuming blanket credit quality across the entire portfolio.

Rite Aid: A Cautionary Tale for NNN Investors

Rite Aid’s well-documented bankruptcy proceedings and subsequent store liquidation program serve as a stark reminder of the credit risk embedded in pharmacy NNN investments. Properties formerly occupied by Rite Aid have flooded select markets, creating both distressed acquisition opportunities and cautionary examples of what happens when essential-use assumptions give way to financial reality. Investors who had concentrated exposure to Rite Aid NNN assets have faced meaningful mark-to-market losses and re-leasing challenges, underscoring the importance of portfolio diversification and rigorous credit analysis.

Key Considerations for Pharmacy NNN Investors in 2026

Prioritize real estate fundamentals: Strong corner locations with high traffic counts and dense surrounding populations provide downside protection regardless of tenant credit fluctuations.
Scrutinize remaining lease term: Shorter lease terms on credit-challenged tenants amplify risk and should be reflected in pricing expectations.
Assess dark value: Understand what the property is worth if the pharmacy tenant vacates — alternative use potential and re-leasing probability matter more than ever.
Diversify across pharmacy credits: Concentrated exposure to any single operator in this sector carries idiosyncratic risk that broad diversification can mitigate.
Monitor corporate announcements: Both Walgreens and CVS continue to evolve their footprint strategies, and staying current on announced closures is essential to avoiding stranded assets.

The Broader Outlook

Pharmacy NNN properties remain a legitimate and relevant component of a well-constructed net lease portfolio in 2026 — but the era of treating all drug store assets as interchangeable, investment-grade certainties is firmly in the past. The sector now rewards investors who combine rigorous underwriting with a clear-eyed assessment of each tenant’s strategic direction and each property’s standalone real estate value. Those who apply that discipline stand to benefit from a market that is offering yields not seen in years, while those who rely on brand recognition alone face meaningful downside exposure.

At Triple Net Direct, we track pharmacy NNN market dynamics continuously to help investors navigate this evolving landscape with confidence and clarity.

Sources

CoStar Group — Pharmacy Net Lease Market Data and Cap Rate Trends (costar.com)
Moody’s Ratings — Walgreens Boots Alliance Credit Assessment Updates (moodys.com)
S&P Global Ratings — CVS Health and Walgreens Credit Profiles (spglobal.com)
The Wall Street Journal — Walgreens Store Closure Strategy and Financial Restructuring Coverage (wsj.com)
Reuters — Rite Aid Bankruptcy Proceedings and Liquidation Reporting (reuters.com)
LoopNet — Pharmacy NNN Listing and Cap Rate Trend Data (loopnet.com)